MDBK acclimation suspension method and two-stage virus production process

A virus and virus liquid technology, applied in double-stranded DNA viruses, biochemical equipment and methods, viruses, etc., can solve the problems of weak nutrient composition of basic medium, long time consumption, restricted nutrient intake, etc., and achieve stable growth state, Good dispersion effect

Pending Publication Date: 2018-09-25
上海健士拜生物科技有限公司 +2
View PDF3 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The defects of the existing MDBK cell acclimatization and suspension are: 1. Some cannot achieve complete serum-free culture; 2. Generally, a two-step method is adopted, that is, first reduce to serum-free and then suspend culture, because the medium used for adherent culture Serum is usually added to the basal medium. The nutrient content of the basal medium is weak, and the surface area / volume ratio of the adherent culture during the domestication process is usually small, which limits the intake of nutrients. The entire domestication process takes a long time; 3. After genetic modification, domestication, That is, through genetic modification, insert gene fragments that are not conducive to adherence into the adherent cell line, change the original adherent culture method, and make the cells grow in suspension, and then through continuous optimization and change of the medium, the cells can be serum-free and high-density. Growth, this method is easy to implement, but the insertion of foreign gene fragments affects the quality of the product
Up to now, there are no related reports on the second-stage culture method of suspension MDBK cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • MDBK acclimation suspension method and two-stage virus production process
  • MDBK acclimation suspension method and two-stage virus production process
  • MDBK acclimation suspension method and two-stage virus production process

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0098] Example 1 Gradual reduction of serum makes adherent MDBK cells adapt to low serum, serum-free and suspension culture

[0099] 1. Experimental materials

[0100] Cell line: MDBK cell line (CCL-22) derived from ATCC.

[0101] Medium: DMEM (high glucose) (JSB-66001) complete basic culture medium, BD004(JSB-DP049), commercial serum-free chemically defined growth medium CD MDBK 211 (JSB-211), both are on the market.

[0102] 2. Method

[0103] Include the following steps:

[0104] (1) The adherent MDBK cells frozen in the liquid nitrogen tank (source of cell line: American ATCC, CCL-22) were directly resuscitated, and placed in a medium containing 10% newborn calf serum (NBCS). Cultivate in DMEM (high glucose) (JSB-66001) complete basal culture medium. After 72h to 96h, observe under a microscope that the MDBK cells are covered with a monolayer, add 0.25% Trypsin-EDTA digestion solution, digest at room temperature for 1 to 3 minutes, and then discard Trypsinized d...

Embodiment 2

[0114] Example 2 Direct domestication of adherent MDBK cells to adapt to low serum, serum-free and suspension culture

[0115] 1. Experimental materials

[0116] Cell line: MDBK cell line (CCL-22) derived from ATCC.

[0117] Medium: BD004(JSB-DP049), CD series serum-free medium ( CD MDCK, CD EB66, CD 022, CD 024, CD 012, CD HEK293), a commercial serum-free chemically defined growth medium CD MDBK 211 (JSB-211), both are on the market.

[0118]2. Method

[0119] Include the following steps:

[0120] (1) The adherent MDBK cells cryopreserved in the liquid nitrogen tank were directly resuscitated in a medium containing 2% newborn bovine serum BD004 (JSB-DP049) was cultured in complete low-serum culture medium. After 48h to 72h, when the MDBK cells covered a single layer under a microscope, 0.25% Trypsin-EDTA digestion solution was added, digested at room temperature for 1 to 3 minutes, and then discarded. Enzymatic digestion solution, with 2% newborn bovine...

Embodiment 3

[0128] Second-stage culture process test of embodiment 3 suspension MDBK cells

[0129] 1. Experimental materials

[0130] Cell line: MDBK cell line (CCL-22) derived from ATCC, which can be grown in suspension after being independently domesticated by Jianshun Biotechnology, and the domestication conditions are as described above.

[0131] Medium: CD MDBK 211 protein-free, animal-source-free, serum-free, chemically defined cell culture medium, independently developed by Jianshun Biology (JSB-211), is now on the market.

[0132] 2. Method

[0133] Include the following steps

[0134] (1) Recovery and passage of cells

[0135] (1) Preparation of medium: Prepare liquid medium according to the instructions CD MDBK21120L, after sterilizing and filtering, store in the dark at 4°C.

[0136] (2) Cell recovery: Take out the frozen cell line from the liquid nitrogen tank, add it to 30mL medium after thawing at 37°C, centrifuge at 1000rpm / min, discard the supernatant, and resuspe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an MDBK cell acclimation suspension method and a two-stage virus production process. According to the MDBK cell acclimation suspension method, adherent MDBK cells are acclimated to adapt to serum-free suspension culture and used as host cells for producing viruses which can have cytopathic effect or sensitivity on suspension MDBK cells by two-stage culture virus inoculation; when the cells grow to 2.0-20.0*10<6> cells / mL, diluting with a production culture medium by 1-5 times is performed to reach a density range of 1.0-10.0*10<6> cells / mL, and then virus inoculation is carried out or virus inoculation is performed before dilution. The suspension MDBK cells are adaptive to suspension growth in the serum-free chemical-defined culture medium, and the two-stage virusproduction process is simple and easy in amplification; liquid changing is avoided, and high culture medium utilization efficiency is achieved; production and growth culture media can be identical ornot and can be mixed proportionally to realize cell secondary growth and viral expression promotion.

Description

technical field [0001] The invention relates to the field of MDBK cell acclimation suspension method and suspension MDBK cell-related vaccine production. The MDBK acclimation suspension method and the second-stage virus production process of the present invention can exist simultaneously or independently in the technical scheme. Specifically, it relates to a process technology for cultivating suspended MDBK cells in a bioreactor above 30L and cultivating the suspended MDBK cells in a second-stage culture method to produce vaccines. Background technique [0002] Mammalian cell large-scale culture technology is one of the downstream common technologies of biopharmaceutical companies, and it plays an extremely important role in this industry. The key to this technology is to achieve large-scale culture of mammalian cells in suspension serum-free, thereby increasing production capacity, reducing costs, and facilitating scale-up. The usual practice in culture of adherent cells i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N7/00C12N7/02A61K39/12A61K39/265A61P31/14A61P31/22
CPCA61K39/12C12N7/00C12N2710/16034C12N2710/16051C12N2770/24334C12N2770/24351
Inventor 蔡仕君侯瑞娟
Owner 上海健士拜生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products